Phil Skolnick

Insider Reports History

Location
Hackensack, NJ
Signature
/s/ Phil Skolnick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Skolnick:

Company Role Class Num Shares Value Price $ Report Date Ownership
OPIANT PHARMACEUTICALS, INC. Chief Scientific Officer Common Stock 0 $20.00 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Scientific Officer Stock Option (right to buy) 0 $10.00 02 Mar 2023 Direct

Insider Reports Filed by Phil Skolnick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000138550823000065-skolnick-phil-2023-03-02 OPIANT PHARMACEUTICALS, INC. 02 Mar 2023 8 -$470,960 4 Chief Scientific Officer 03 Mar 2023, 08:13
/report/000138550823000031-skolnick-phil-2023-01-27 OPIANT PHARMACEUTICALS, INC. 27 Jan 2023 1 -$9,725 4 Chief Scientific Officer 31 Jan 2023, 15:19
/report/000138550823000020-skolnick-phil-2023-01-09 OPIANT PHARMACEUTICALS, INC. 09 Jan 2023 1 -$7,454 4 Chief Scientific Officer 09 Jan 2023, 16:11
/report/000138550823000007-skolnick-phil-2023-01-05 OPIANT PHARMACEUTICALS, INC. 05 Jan 2023 1 -$28,704 4 Chief Scientific Officer 05 Jan 2023, 15:56
/report/000138550822000111-skolnick-phil-2022-07-14 OPIANT PHARMACEUTICALS, INC. 14 Jul 2022 1 -$7,430 4 Chief Scientific Officer 15 Jul 2022, 16:05
/report/000138550822000101-skolnick-phil-2022-06-27 OPIANT PHARMACEUTICALS, INC. 27 Jun 2022 1 $0 4 Chief Scientific Officer 29 Jun 2022, 16:03
/report/000138550822000026-skolnick-phil-2022-01-27 OPIANT PHARMACEUTICALS, INC. 27 Jan 2022 1 -$39,756 4 Chief Scientific Officer 27 Jan 2022, 15:05
/report/000138550822000021-skolnick-phil-2022-01-10 OPIANT PHARMACEUTICALS, INC. 10 Jan 2022 1 -$11,739 4 Chief Scientific Officer 12 Jan 2022, 15:37
/report/000138550822000013-skolnick-phil-2022-01-04 OPIANT PHARMACEUTICALS, INC. 04 Jan 2022 1 $0 4 Chief Scientific Officer 05 Jan 2022, 15:22